Road transport minister Nitin Gadkari criticized engineers, consultants, and contractors for neglecting road safety, citing faulty planning and poor signage as primary causes of accidents.
Neil Nitin Mukesh reflected on his career struggles despite 20 years in Bollywood and revealed that he still messages people to ask for work. Neil Nitin Mukesh, who has appeared in popular ...
In a recent interview, Neil Nitin Mukesh revealed that Katrina Kaif scolded him once, following which he decided to confront her and clear up things. Released in 2009, New York also featured John ...
New Delhi: In a celebration of entrepreneurial excellence, Nithin Kamath, Founder and Chief Executive Officer, Zerodha, has been awarded the esteemed EY Entrepreneur Of The Yearâ„¢ Award 2024 (EOY).
This trial was flagged off by Nitin Gadkari, Union Minister of Road Transport & Highways, Pralhad Joshi, Union Minister of New and Renewable Energy. Flagging-off the trial, Nitin Gadkari ...
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing ...
Zerodha co-founder Nikhil Kamath, in a post on X, showered praise on his brother, Nithin Kamath, after he won the EY Entrepreneur of the Year Award 2024. Hailing Nithin and his wife Seema Patil ...
NEW YORK & COPENHAGEN--(BUSINESS WIRE)--Accenture (NYSE: ACN) has acquired Halfspace, a leading and multi-award-winning Denmark-based AI company that helps organizations leverage and scale AI to ...
Zerodha co-founder Nithin Kamath responded to Pullela Gopichand's advice against pursuing professional sports without financial backing. Kamath acknowledged Gopichand's concerns but argued that ...
Kamath also strongly discouraged borrowing money to invest. With the stock market experiencing a significant correction, Zerodha CEO Nithin Kamath has shared key insights for investors ...
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr. Reddy's Laboratories are shifting their focus to a promising new frontier ...